SARS-CoV-2 structural features may explain limited neutralizing-antibody responses

被引:43
|
作者
Bachmann, Martin F. [1 ,2 ,3 ]
Mohsen, Mona O. [2 ,3 ]
Zha, Lisha [1 ]
Vogel, Monique [1 ]
Speiser, Daniel E. [4 ,5 ]
机构
[1] Anhui Agr Univ, Int Immunol Ctr, Hefei, Peoples R China
[2] Univ Hosp Bern, Dept Rheumatol Immunol & Allergol, Bern, Switzerland
[3] Univ Bern, Dept BioMed Res, Bern, Switzerland
[4] Univ Hosp, Lausanne, Switzerland
[5] Univ Lausanne, Lausanne, Switzerland
基金
瑞士国家科学基金会;
关键词
CORONAVIRUS; IMMUNITY; CELL; ANTIGEN; IMMUNOGENICITY; INFECTION;
D O I
10.1038/s41541-020-00264-6
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Neutralizing antibody responses of SARS-CoV-2-infected patients may be low and of short duration. We propose here that coronaviruses employ a structural strategy to avoid strong and enduring antibody responses. Other viruses induce optimal and long-lived neutralizing antibody responses, thanks to 20 or more repetitive, rigid antigenic epitopes, spaced by 5-10nm, present on the viral surface. Such arrays of repetitive and highly organized structures are recognized by the immune system as pathogen-associated structural patterns (PASPs), which are characteristic for pathogen surfaces. In contrast, coronaviruses are large particles with long spikes (S protein) embedded in a fluid membrane. Therefore, the neutralizing epitopes (which are on the S protein) are loosely "floating" and widely spaced by an average of about 25nm. Consequently, recruitment of complement is poor and stimulation of B cells remains suboptimal, offering an explanation for the inefficient and short-lived neutralizing antibody responses.
引用
收藏
页数:5
相关论文
共 50 条
  • [1] SARS-CoV-2 structural features may explain limited neutralizing-antibody responses
    Martin F. Bachmann
    Mona O. Mohsen
    Lisha Zha
    Monique Vogel
    Daniel E. Speiser
    npj Vaccines, 6
  • [2] Infection and Vaccine-Induced Neutralizing-Antibody Responses to the SARS-CoV-2 B.1.617 Variants
    Edara, Venkata-Viswanadh
    Pinsky, Benjamin A.
    Suthar, Mehul S.
    Lai, Lilin
    Davis-Gardner, Meredith E.
    Floyd, Katharine
    Flowers, Maria W.
    Wrammert, Jens
    Hussaini, Laila
    Ciric, Caroline Rose
    Bechnak, Sarah
    Stephens, Kathy
    Graham, Barney S.
    Bayat Mokhtari, Elham
    Mudvari, Prakriti
    Boritz, Eli
    Creanga, Adrian
    Pegu, Amarendra
    Derrien-Colemyn, Alexandrine
    Henry, Amy R.
    Gagne, Matthew
    Douek, Daniel C.
    Sahoo, Malaya K.
    Sibai, Mamdouh
    Solis, Daniel
    Webby, Richard J.
    Jeevan, Trushar
    Fabrizio, Thomas P.
    NEW ENGLAND JOURNAL OF MEDICINE, 2021, 385 (07): : 664 - 666
  • [3] Sex Disparities and Neutralizing-Antibody Durability to SARS-CoV-2 Infection in Convalescent Individuals
    Markmann, Alena J.
    Giallourou, Natasa
    Bhowmik, D. Ryan
    Hou, Yixuan J.
    Lerner, Aaron
    Martinez, David R.
    Premkumar, Lakshmanane
    Root, Heather
    van Duin, David
    Napravnik, Sonia
    Graham, Stephen D.
    Guerra, Quique
    Raut, Rajendra
    Petropoulos, Christos J.
    Wrin, Terri
    Cornaby, Caleb
    Schmitz, John
    Kuruc, JoAnn
    Weiss, Susan
    Park, Yara
    Baric, Ralph
    de Silva, Aravinda M.
    Margolis, David M.
    Bartelt, Luther A.
    MSPHERE, 2021, 6 (04)
  • [4] Functional and structural investigation of a broadly neutralizing SARS-CoV-2 antibody
    Chang, Yi-Hsuan
    Hsu, Min-Feng
    Chen, Wei-Nan
    Wu, Min-Hao
    Kong, Wye-Lup
    Lu, Mei-Yeh Jade
    Huang, Chih-Heng
    Chang, Fang-Ju
    Chang, Lan-Yi
    Tsai, Ho-Yang
    Tung, Chao -Ping
    Yu, Jou-Hui
    Kuo, Yali
    Chou, Yu -Chi
    Bai, Li -Yang
    Chang, Yuan-Chih
    Chen, An -Yu
    Chen, Cheng-Cheung
    Chen, Yi-Hua
    Liao, Chun-Che
    Chang, Chih-Shin
    Liang, Jian-Jong
    Lin, Yi-Ling
    Angata, Takashi
    Hsu, Shang-Te Danny
    Lin, Kuo-, I
    JCI INSIGHT, 2024, 9 (10)
  • [5] Elucidating important structural features for the binding affinity of spike - SARS-CoV-2 neutralizing antibody complexes
    Sharma, Divya
    Rawat, Puneet
    Janakiraman, Vani
    Gromiha, M. Michael
    PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS, 2022, 90 (03) : 824 - 834
  • [6] Neutralizing antibody responses to SARS-CoV-2: A population based seroepidemiological analysis
    Sharma, Pragya
    Gupta, Ekta
    Basu, Saurav
    Agarwal, Reshu
    Mishra, Suruchi
    Kale, Pratibha
    Mundeja, Nutan
    Charan, B. S.
    Singh, Gautam Kumar
    Singh, M. M.
    INDIAN JOURNAL OF MEDICAL MICROBIOLOGY, 2022, 40 (04) : 585 - 587
  • [7] Neutralizing and binding antibody responses to SARS-CoV-2 with hybrid immunity in pregnancy
    Li, Lin
    Matsui, Yusuke
    Prahl, Mary K.
    Cassidy, Arianna G.
    Golan, Yarden
    Jigmeddagva, Unurzul
    Ozarslan, Nida
    Lin, Christine Y.
    Buarpung, Sirirak
    Gonzalez, Veronica J.
    Chidboy, Megan A.
    Basilio, Emilia
    Lynch, Kara L.
    Song, Dongli
    Jegatheesan, Priya
    Rai, Daljeet S.
    Govindaswami, Balaji
    Needens, Jordan
    Rincon, Monica
    Myatt, Leslie
    Taha, Taha Y.
    Montano, Mauricio
    Ott, Melanie
    Greene, Warner C.
    Gaw, Stephanie L.
    NPJ VACCINES, 2024, 9 (01)
  • [8] Insights into neutralizing antibody responses in individuals exposed to SARS-CoV-2 in Chile
    Beltran-Pavez, Carolina
    Riquelme-Barrios, Sebastian
    Oyarzun-Arrau, Aaron
    Gaete-Argel, Aracelly
    Gonzalez-Stegmaier, Roxana
    Cereceda-Solis, Karina
    Aguirre, Adam
    Travisany, Dante
    Palma-Vejares, Ricardo
    Barriga, Gonzalo P.
    Gaggero, Aldo
    Martinez-Valdebenito, Constanza
    Le Corre, Nicole
    Ferres, Marcela
    Balcells, Maria Elvira
    Fernandez, Jorge
    Ramirez, Eugenio
    Villarroel, Franz
    Valiente-Echeverria, Fernando
    Soto-Rifo, Ricardo
    SCIENCE ADVANCES, 2021, 7 (07):
  • [9] Neutralizing antibody responses to SARS-CoV-2 in COVID-19 patients
    Deshpande, Gururaj Rao
    Sapkal, Gajanan N.
    Tilekar, Bipin N.
    Yadav, Pragya D.
    Gurav, Yogesh
    Gaikwad, Shivshankar
    Kaushal, Himanshu
    Deshpande, Ketki S.
    Kaduskar, Ojas
    Sarkale, Prasad
    Baradkar, Srikant
    Suryawanshi, Annasaheb
    Lakra, Rajen
    Sugunan, A. P.
    Balakrishnan, Anukumar
    Abraham, Priya
    Salve, Pavan
    INDIAN JOURNAL OF MEDICAL RESEARCH, 2020, 152 (01) : 82 - 87
  • [10] SARS-CoV-2 neutralizing antibody development strategies
    Balcioglu, Bertan Koray
    Oncu, Melis Denizci
    Ozturk, Hasan Umit
    Yucel, Fatima
    Kaya, Filiz
    Serhatli, Muge
    Polat, Hivda Ulbegi
    Tekin, Saban
    Bahadir, Aylin Ozdemir
    TURKISH JOURNAL OF BIOLOGY, 2020, 44 (03) : 203 - 214